A detailed history of Royal Bank Of Canada transactions in Zynex Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 1,672 shares of ZYXI stock, worth $13,660. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,672
Previous 1,493 11.99%
Holding current value
$13,660
Previous $13,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.19 - $10.31 $1,287 - $1,845
179 Added 11.99%
1,672 $13,000
Q2 2024

Aug 14, 2024

SELL
$8.63 - $12.56 $16,888 - $24,579
-1,957 Reduced 56.72%
1,493 $13,000
Q1 2024

Nov 05, 2024

BUY
$9.86 - $13.74 $19,296 - $26,889
1,957 Added 131.08%
3,450 $42,000
Q1 2024

May 15, 2024

SELL
$9.86 - $13.74 $67,521 - $94,091
-6,848 Reduced 66.5%
3,450 $42,000
Q4 2023

Feb 14, 2024

BUY
$7.1 - $10.89 $34,108 - $52,315
4,804 Added 87.44%
10,298 $112,000
Q3 2023

Nov 14, 2023

SELL
$6.95 - $9.89 $93,533 - $133,099
-13,458 Reduced 71.01%
5,494 $43,000
Q2 2023

Aug 14, 2023

BUY
$8.59 - $14.56 $125,371 - $212,503
14,595 Added 334.98%
18,952 $181,000
Q1 2023

May 15, 2023

SELL
$9.53 - $16.8 $11,321 - $19,958
-1,188 Reduced 21.42%
4,357 $52,000
Q4 2022

Feb 14, 2023

BUY
$8.71 - $14.28 $12,725 - $20,863
1,461 Added 35.77%
5,545 $77,000
Q3 2022

Nov 14, 2022

BUY
$7.19 - $9.91 $733 - $1,010
102 Added 2.56%
4,084 $36,000
Q2 2022

Aug 15, 2022

SELL
$5.78 - $8.87 $7,219 - $11,078
-1,249 Reduced 23.88%
3,982 $32,000
Q1 2022

May 16, 2022

SELL
$5.14 - $9.35 $9,925 - $18,054
-1,931 Reduced 26.96%
5,231 $33,000
Q4 2021

Feb 14, 2022

SELL
$8.71 - $13.77 $38,550 - $60,946
-4,426 Reduced 38.19%
7,162 $71,000
Q3 2021

Nov 15, 2021

SELL
$10.35 - $15.65 $133,742 - $202,229
-12,922 Reduced 52.72%
11,588 $133,000
Q2 2021

Aug 16, 2021

BUY
$12.25 - $14.87 $300,247 - $364,463
24,510 New
24,510 $381,000

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $306M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.